SlideShare uma empresa Scribd logo
1 de 49
HYPERTENSIVE
RETINOPATHY
RONALD MAMBOLEO
LAYOUT:
INTRODUCTION
RISK FACTORS
PATHOGENESIS
CLINICAL FEATURES
DIAGNOSIS
MANAGEMENT
INTRODUCTION
• Hypertensive retinopathy refers to fundus changes occurring in
patient suffering from systemic hypertension.
• Uncontrolled systemic hypertension leads to non-perfusion at
various retinal levels and to neuronal loss and related scotomata.
INTRODUCTION CONT…
• It is usually Bilateral and Symmetrical
• Small blood vessel disease caused by systemic hypertension
 Acute or chronic
 Systolic or diastolic
• End organ disease manifestation
OCULAR MANIFESTATION
• Hypertensive retinopathy
• Hypertensive optic neuropathy
• Hypertensive choroidopathy
PREVALENCE
• The second most common retinal vascular disease
• Systemic hypertension (>160/90mmHg) 10-15% of cases in UK with
>40 years
• Malignant hypertension (240/140mmhg) 0.5-0.75%
• Hypertensive retinopathy 4-10%
• In Africa the prevalence rate of HTN is 33% and in Kenya
the prevalence rate of HTN is 26%.
• There is paucity of data in sub-saharan Africa
• Prevalence in kenya 2018 (MTRH) was at 23.3% ; 84 %
grade 1 ,13% grade 2 , 3 % had grade 3.
RISK FACTORS
• Afro-Caribbeans = relative risk factor 2x
• Age
• Family history
• Obesity
• Smoking
• Stress
• Alcohol consumption
• Lack of exercise
PATHOGENESIS
Factors which play role in the pathogenesis of hypertensive retinopathy include:
1. Vasospasm
 narrowing of arteries in the primary response to raised blood pressure and is related
to the severity of hypertension.
 Vasospasm of retinal arterioles occurs in pure form in young individuals, but is
affected by the pre-existing involutional sclerosis in older patients.
 Vasospasm of choroidal vessels causes choroidal and RPE ischaemia, resulting to
hypertensive choroidopathy.
 Vasospasm of peripapillary choroid leads to optic nerve head ischaemia, manifesting
as hypertensive optic neuropathy.
ARTERIOLAR NARROWING
2. ARTERIOSCLEROTIC CHANGES
• Manifest as changes in the arteriolar reflex and A-V nipping result from
thickening of the vessel wall and are a reflection of the duration of hypertension
(chronic hypertension).
• In older patients, arteriosclerotic changes may pre-exist due to involutional
sclerosis.
3. INCREASED VASCULAR PERMEABILITY.
• Results from hypoxia causing breakdown of inner blood
retinal barrier and occurs in severs hypertension
• Is responsible for haemorrhages, exudates, focal retinal
oedema, macular oedema, focal intraretinal periarterial
transudates (FlPTs), and disc oedema.
HAEMORRAGES AND EXUDATES
4. RAISED INTRACRANIAL PRESSURE
• Occurs in malignant or accelerated hypertension
• manifests as hypertensive optic neuropathy, characterized
by papilloedema and optic nerve ischemia.
PAPILLLOEDEMA
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY
1. Generalized arterial narrowing - consists of vasoconstrictive phase due to
vasospasm and sclerotic phases due to intimal thickening, hypoplasia of tunica
media and hyaline degeneration.
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY CT
2 Focal arteriolar narrowing is seen as areas of localized vasoconstriction on the
disc.
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY CT
3 Arteriovenous nicking is the hallmark of hypertensive retinopathy and occurs
where arteriole crosses and compresses the vein.
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY CT
4. Arteriolar reflex changes. The normal light reflex of the retinal vasculature is
formed by the reflection from the interface between the blood column and vessel
wall.
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY CT
5 Superficial retinal hemorrhages (flame-shaped) occur at the posterior pole due to
disruption of the capillaries in the retinal nerve fibre layer.
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY
6. Hard exudates are lipid deposits in the outer pleixform layer of retina which occur
following leaky capillaries in severe hypertensive retinopathy. They appear as
yellowish waxy spots with sharp margins.
FUNDUS CHANGES OF CHRONIC HYPERTENSIVE
RETINOPATHY CT
• 7. Cotton wool spots - fluffy white lesions and represent the areas of infarcts in
the nerve fibre layer, due to ischemia
MALIGNANT HYPERTENSION
• Expression of hypertension rapid progression to a serious degree in a patient with
relatively young arterioles undefended by fibrosis.
• Marked arteriolar narrowing
• Papilloedema
MALIGNANT HYPERTENSION
• Retinal edema over posterior pole
• Superficial flame shaped haemorrhages
• Abundance of cotton wool patches
ACUTE HYPERTENSIVE CHOROIDOPATHY
• It is primarily due to choroidal ischemia, which produces ischaemic damage to the
overlying retinal pigment epithelium
• Fundus changes include:
1. Acute focal retinal pigment epitheliopathy - characterised by focal white spots,
occurs due to acute ischaemic changes in choriocapillaries
ACUTE HYPERTENSIVE CHOROIDOPATHY CT
2 :Elschnig's spots - small black spots surrounded by yellow halos, due to clumping
and atrophy of the infarcted pigment epithelium.
ACUTE HYPERTENSIVE CHOROIDOPATHY CT
3. Siegrist streaks - formed due to linear configuration of the pigment along the
choroidal arterioles. These are formed due to fibrinoid necrosis associated with
malignant hypertension.
ACUTE HYPERTENSIVE CHOROIDOPATHY CT
4. Serous neurosensory retinal detachment - affects the macular area, may occur
due to accumulation of fluid beneath the retina following breakdown of outer
blood-retinal barrier owing to ischemic damage.
ACUTE HYPERTENSIVE OPTIC NEUROPATHY
Changes include:
• Disc oedema and haemorrhages on the disc and peripapillary retina due to
vasoconstriction of peripapillary choroidal vessels supplying the optic nerve head.
• Disc pallor, of variable degree, may occur late in the course of disease.
RETINOPATHY IN PREGNANCY-INDUCED
HYPERTENSION
• Pregnancy-induced hypertension (PIH), previously known as 'toxaemia’ of
pregnancy; is a disease of unknown etiology
• Characterised by raised blood pressure, proteinuria and generalised oedema.
• Retinal changes in PIH – occur in BP above 160/ 100 mm of Hg and are marked
BP rises above 200/ 130 mm of Hg.
RETINAL CHANGES IN PIH
• Earliest changes - narrowing of foveal and nasal arterioles, followed by
generalised narrowing.
• Severe persistent spasm of vessels – Cause retinal hypoxia characterised by
appearance of 'cotton wool spots' and superficial haemorrhages.
• progression of retinopathy occurs rapidly if pregnancy is allowed to continue and
changes of hypertensive opticn neuropathy and acute choroido pathy (Elschnig
spots and other RPE lesions) can occur.
RETINAL CHANGES IN PIH
• Retinal oedema and exudation is usually marked.
• Rarely, bilateral exudative retinal detachment.
• Prognosis for retinal reattachment is good, as it occurs spontaneously within a
few days of termination of pregnancy.
RETINOPATHY IN PIH
MANAGEMENT OF PIH
• Retinal changes disappear after delivery unless organic vascular disease occurs
• Pre organic stage- manage as pregnancy continues
• Advanced hypoxic retinopathy-soft exudates, retinal edema and hemorrhages- terminate
the pregnancy
HISTORY AND SYMPTOMS
• Possible history of systemic hypertension
• Systemic hypertension largely asymptomatic
• Hypertensive retinopathy largely asymptomatic
• The eye examination will often give the first clue of systemic hypertension
DIAGNOSIS
Ophthalmoscopy (non-malignant retinopathy)
• Arteriosclerosis from chronic disease
 focal arteriolar narrowing
 arterio-venous crossing changes
-venous constriction and deflection
-distal banking
 arteriolar colour changes
 vessel sclerosis
• Similar signs with ageing
CONT..
• Sphygmomanometry
• Blood pressure measurement is required to make a positive diagnosis in the absence of
malignant retinopathy changes
DISC OEDEMA AND HAEMORRHAGES
HYPERTENSIVE RETINOPATHY STAR
EXUDATES AND HAEMORRAGHAGES
BASED ON PRESENCE OF SYSTEMIC HTN AND
RETINAL EXAM:
MANAGEMENT
1). Control Systemic Hypertension
• Life style modification to control systemic HTN
• Drugs to reduce systemic HTN
2) Hypertensive Retinopathy with visual threatening complications
e.g retinal edema
• With laser therapy
• Intravitreal injection of vascular endothelial growth factors(VEGF)
REFFERENCES
• American Academy of ophthalmology
• Comprehensive Ophthalmology 9th Edition A K Khurana
• Kanski 9th Edition Clinical Ophthalmology.
• Magara, G. M. (2022). Prevalence of Uncontrolled Hypertension and Associated Factors among Hypertensive Patients
Attending Medical Outpatient Clinic, Thika Level 5 Hospital, Kiambu County, Kenya (Doctoral dissertation, JKUAT-
COHES).
• Rakwach, M. O. (2021). Prevalence and risk factors for hypertensive retinopathy at Moi Teaching and Referral
Hospital, Eldoret, Kenya (Doctoral dissertation, Moi University).
END
THANK YOU

Mais conteúdo relacionado

Semelhante a HYPERTENSIVE RETINOPATHY.2023 12111325246pptx

Diabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathyDiabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathy
Vineela Cherukuri
 
IIH BY DR DINESH.pptx sms hospital jaipur rajasthan
IIH BY DR DINESH.pptx sms hospital jaipur rajasthanIIH BY DR DINESH.pptx sms hospital jaipur rajasthan
IIH BY DR DINESH.pptx sms hospital jaipur rajasthan
dineshdandia
 

Semelhante a HYPERTENSIVE RETINOPATHY.2023 12111325246pptx (20)

Vascular disorders of eye
Vascular disorders of eyeVascular disorders of eye
Vascular disorders of eye
 
Diabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathyDiabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathy
 
Other Retinal Vascular Diseases.pptx
Other Retinal Vascular Diseases.pptxOther Retinal Vascular Diseases.pptx
Other Retinal Vascular Diseases.pptx
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathy
 
Vascular disorders of retina
Vascular disorders of retinaVascular disorders of retina
Vascular disorders of retina
 
Structural and oct changes in diabetic retinopathy1
Structural and oct changes in diabetic retinopathy1Structural and oct changes in diabetic retinopathy1
Structural and oct changes in diabetic retinopathy1
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertension
 
Nephrosclerosis
NephrosclerosisNephrosclerosis
Nephrosclerosis
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathy
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive Retinopathy
 
HYPERTENSIVE RETINOPATHY power point.pptx
HYPERTENSIVE RETINOPATHY power point.pptxHYPERTENSIVE RETINOPATHY power point.pptx
HYPERTENSIVE RETINOPATHY power point.pptx
 
Ophthalmology Revision
Ophthalmology RevisionOphthalmology Revision
Ophthalmology Revision
 
Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)
Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)
Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)
 
IIH BY DR DINESH.pptx sms hospital jaipur rajasthan
IIH BY DR DINESH.pptx sms hospital jaipur rajasthanIIH BY DR DINESH.pptx sms hospital jaipur rajasthan
IIH BY DR DINESH.pptx sms hospital jaipur rajasthan
 
Dr.Amit Anand Cerebral Venous Thrombosis.pptx
Dr.Amit Anand Cerebral Venous Thrombosis.pptxDr.Amit Anand Cerebral Venous Thrombosis.pptx
Dr.Amit Anand Cerebral Venous Thrombosis.pptx
 
BIRTH INJURIES.pptx
BIRTH INJURIES.pptxBIRTH INJURIES.pptx
BIRTH INJURIES.pptx
 
HYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptxHYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptx
 
OTHER RETINAL VASCULAR DISEASES by Iddi.pptx
OTHER RETINAL VASCULAR DISEASES by Iddi.pptxOTHER RETINAL VASCULAR DISEASES by Iddi.pptx
OTHER RETINAL VASCULAR DISEASES by Iddi.pptx
 
OTHER RETINAL VASCULAR DISEASES by Iddi.pptx
OTHER RETINAL VASCULAR DISEASES by Iddi.pptxOTHER RETINAL VASCULAR DISEASES by Iddi.pptx
OTHER RETINAL VASCULAR DISEASES by Iddi.pptx
 
Presentation.pptx
Presentation.pptxPresentation.pptx
Presentation.pptx
 

Mais de MuliChristopherKimeu

15.0. Alternative feeding methods -preterm low birth babies.pptx
15.0. Alternative feeding methods  -preterm low birth babies.pptx15.0. Alternative feeding methods  -preterm low birth babies.pptx
15.0. Alternative feeding methods -preterm low birth babies.pptx
MuliChristopherKimeu
 

Mais de MuliChristopherKimeu (12)

Gingivitis and Periodontal Disease. 1245484543458pptx
Gingivitis and Periodontal Disease. 1245484543458pptxGingivitis and Periodontal Disease. 1245484543458pptx
Gingivitis and Periodontal Disease. 1245484543458pptx
 
PHARYNGITIS in patients. 2023. pptx 23153114
PHARYNGITIS in patients. 2023. pptx 23153114PHARYNGITIS in patients. 2023. pptx 23153114
PHARYNGITIS in patients. 2023. pptx 23153114
 
VIRAL HEPATITIS 4th year 2023.114221321pptx
VIRAL HEPATITIS 4th year 2023.114221321pptxVIRAL HEPATITIS 4th year 2023.114221321pptx
VIRAL HEPATITIS 4th year 2023.114221321pptx
 
Epistaxis(1) on pediatrics 1213045341426.pptx
Epistaxis(1) on pediatrics 1213045341426.pptxEpistaxis(1) on pediatrics 1213045341426.pptx
Epistaxis(1) on pediatrics 1213045341426.pptx
 
REPRODUCTIVE SYSTEM PHYSIOLOGY pkl 2414437kptx
REPRODUCTIVE SYSTEM PHYSIOLOGY pkl 2414437kptxREPRODUCTIVE SYSTEM PHYSIOLOGY pkl 2414437kptx
REPRODUCTIVE SYSTEM PHYSIOLOGY pkl 2414437kptx
 
16.0. Overcoming Difficulties in breastfeeding.pptx
16.0. Overcoming Difficulties in breastfeeding.pptx16.0. Overcoming Difficulties in breastfeeding.pptx
16.0. Overcoming Difficulties in breastfeeding.pptx
 
14.0. Breastfeeding The Newborn. 25326442523pptx
14.0. Breastfeeding The Newborn. 25326442523pptx14.0. Breastfeeding The Newborn. 25326442523pptx
14.0. Breastfeeding The Newborn. 25326442523pptx
 
15.0. Alternative feeding methods -preterm low birth babies.pptx
15.0. Alternative feeding methods  -preterm low birth babies.pptx15.0. Alternative feeding methods  -preterm low birth babies.pptx
15.0. Alternative feeding methods -preterm low birth babies.pptx
 
INTRODUCTION TO PHARMACOLOGY ONE 143245456325723.pptx
INTRODUCTION TO PHARMACOLOGY ONE 143245456325723.pptxINTRODUCTION TO PHARMACOLOGY ONE 143245456325723.pptx
INTRODUCTION TO PHARMACOLOGY ONE 143245456325723.pptx
 
BRONCHIOLITIS 1 pharm . 1211116363026323pptx
BRONCHIOLITIS 1 pharm . 1211116363026323pptxBRONCHIOLITIS 1 pharm . 1211116363026323pptx
BRONCHIOLITIS 1 pharm . 1211116363026323pptx
 
Birth Trauma in pediatrics 1511205634525 pptx
Birth Trauma in pediatrics 1511205634525 pptxBirth Trauma in pediatrics 1511205634525 pptx
Birth Trauma in pediatrics 1511205634525 pptx
 
Meconium Aspiration. In neonates pptx...
Meconium Aspiration. In neonates pptx...Meconium Aspiration. In neonates pptx...
Meconium Aspiration. In neonates pptx...
 

Último

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 

Último (20)

Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Hepar Sulphuris Remedy, Homoeopathic Materia Medica, HMM, 1st BhMS
Hepar Sulphuris Remedy, Homoeopathic Materia Medica, HMM, 1st BhMSHepar Sulphuris Remedy, Homoeopathic Materia Medica, HMM, 1st BhMS
Hepar Sulphuris Remedy, Homoeopathic Materia Medica, HMM, 1st BhMS
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 

HYPERTENSIVE RETINOPATHY.2023 12111325246pptx

  • 3. INTRODUCTION • Hypertensive retinopathy refers to fundus changes occurring in patient suffering from systemic hypertension. • Uncontrolled systemic hypertension leads to non-perfusion at various retinal levels and to neuronal loss and related scotomata.
  • 4. INTRODUCTION CONT… • It is usually Bilateral and Symmetrical • Small blood vessel disease caused by systemic hypertension  Acute or chronic  Systolic or diastolic • End organ disease manifestation
  • 5. OCULAR MANIFESTATION • Hypertensive retinopathy • Hypertensive optic neuropathy • Hypertensive choroidopathy
  • 6. PREVALENCE • The second most common retinal vascular disease • Systemic hypertension (>160/90mmHg) 10-15% of cases in UK with >40 years • Malignant hypertension (240/140mmhg) 0.5-0.75% • Hypertensive retinopathy 4-10%
  • 7. • In Africa the prevalence rate of HTN is 33% and in Kenya the prevalence rate of HTN is 26%. • There is paucity of data in sub-saharan Africa • Prevalence in kenya 2018 (MTRH) was at 23.3% ; 84 % grade 1 ,13% grade 2 , 3 % had grade 3.
  • 8. RISK FACTORS • Afro-Caribbeans = relative risk factor 2x • Age • Family history • Obesity • Smoking • Stress • Alcohol consumption • Lack of exercise
  • 9. PATHOGENESIS Factors which play role in the pathogenesis of hypertensive retinopathy include: 1. Vasospasm  narrowing of arteries in the primary response to raised blood pressure and is related to the severity of hypertension.  Vasospasm of retinal arterioles occurs in pure form in young individuals, but is affected by the pre-existing involutional sclerosis in older patients.  Vasospasm of choroidal vessels causes choroidal and RPE ischaemia, resulting to hypertensive choroidopathy.  Vasospasm of peripapillary choroid leads to optic nerve head ischaemia, manifesting as hypertensive optic neuropathy.
  • 11. 2. ARTERIOSCLEROTIC CHANGES • Manifest as changes in the arteriolar reflex and A-V nipping result from thickening of the vessel wall and are a reflection of the duration of hypertension (chronic hypertension). • In older patients, arteriosclerotic changes may pre-exist due to involutional sclerosis.
  • 12. 3. INCREASED VASCULAR PERMEABILITY. • Results from hypoxia causing breakdown of inner blood retinal barrier and occurs in severs hypertension • Is responsible for haemorrhages, exudates, focal retinal oedema, macular oedema, focal intraretinal periarterial transudates (FlPTs), and disc oedema.
  • 14. 4. RAISED INTRACRANIAL PRESSURE • Occurs in malignant or accelerated hypertension • manifests as hypertensive optic neuropathy, characterized by papilloedema and optic nerve ischemia.
  • 16.
  • 17.
  • 18.
  • 19. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY 1. Generalized arterial narrowing - consists of vasoconstrictive phase due to vasospasm and sclerotic phases due to intimal thickening, hypoplasia of tunica media and hyaline degeneration.
  • 20. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY CT 2 Focal arteriolar narrowing is seen as areas of localized vasoconstriction on the disc.
  • 21. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY CT 3 Arteriovenous nicking is the hallmark of hypertensive retinopathy and occurs where arteriole crosses and compresses the vein.
  • 22. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY CT 4. Arteriolar reflex changes. The normal light reflex of the retinal vasculature is formed by the reflection from the interface between the blood column and vessel wall.
  • 23. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY CT 5 Superficial retinal hemorrhages (flame-shaped) occur at the posterior pole due to disruption of the capillaries in the retinal nerve fibre layer.
  • 24. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY 6. Hard exudates are lipid deposits in the outer pleixform layer of retina which occur following leaky capillaries in severe hypertensive retinopathy. They appear as yellowish waxy spots with sharp margins.
  • 25. FUNDUS CHANGES OF CHRONIC HYPERTENSIVE RETINOPATHY CT • 7. Cotton wool spots - fluffy white lesions and represent the areas of infarcts in the nerve fibre layer, due to ischemia
  • 26. MALIGNANT HYPERTENSION • Expression of hypertension rapid progression to a serious degree in a patient with relatively young arterioles undefended by fibrosis. • Marked arteriolar narrowing • Papilloedema
  • 27. MALIGNANT HYPERTENSION • Retinal edema over posterior pole • Superficial flame shaped haemorrhages • Abundance of cotton wool patches
  • 28. ACUTE HYPERTENSIVE CHOROIDOPATHY • It is primarily due to choroidal ischemia, which produces ischaemic damage to the overlying retinal pigment epithelium • Fundus changes include: 1. Acute focal retinal pigment epitheliopathy - characterised by focal white spots, occurs due to acute ischaemic changes in choriocapillaries
  • 29. ACUTE HYPERTENSIVE CHOROIDOPATHY CT 2 :Elschnig's spots - small black spots surrounded by yellow halos, due to clumping and atrophy of the infarcted pigment epithelium.
  • 30. ACUTE HYPERTENSIVE CHOROIDOPATHY CT 3. Siegrist streaks - formed due to linear configuration of the pigment along the choroidal arterioles. These are formed due to fibrinoid necrosis associated with malignant hypertension.
  • 31. ACUTE HYPERTENSIVE CHOROIDOPATHY CT 4. Serous neurosensory retinal detachment - affects the macular area, may occur due to accumulation of fluid beneath the retina following breakdown of outer blood-retinal barrier owing to ischemic damage.
  • 32. ACUTE HYPERTENSIVE OPTIC NEUROPATHY Changes include: • Disc oedema and haemorrhages on the disc and peripapillary retina due to vasoconstriction of peripapillary choroidal vessels supplying the optic nerve head. • Disc pallor, of variable degree, may occur late in the course of disease.
  • 33. RETINOPATHY IN PREGNANCY-INDUCED HYPERTENSION • Pregnancy-induced hypertension (PIH), previously known as 'toxaemia’ of pregnancy; is a disease of unknown etiology • Characterised by raised blood pressure, proteinuria and generalised oedema. • Retinal changes in PIH – occur in BP above 160/ 100 mm of Hg and are marked BP rises above 200/ 130 mm of Hg.
  • 34. RETINAL CHANGES IN PIH • Earliest changes - narrowing of foveal and nasal arterioles, followed by generalised narrowing. • Severe persistent spasm of vessels – Cause retinal hypoxia characterised by appearance of 'cotton wool spots' and superficial haemorrhages. • progression of retinopathy occurs rapidly if pregnancy is allowed to continue and changes of hypertensive opticn neuropathy and acute choroido pathy (Elschnig spots and other RPE lesions) can occur.
  • 35. RETINAL CHANGES IN PIH • Retinal oedema and exudation is usually marked. • Rarely, bilateral exudative retinal detachment. • Prognosis for retinal reattachment is good, as it occurs spontaneously within a few days of termination of pregnancy.
  • 37. MANAGEMENT OF PIH • Retinal changes disappear after delivery unless organic vascular disease occurs • Pre organic stage- manage as pregnancy continues • Advanced hypoxic retinopathy-soft exudates, retinal edema and hemorrhages- terminate the pregnancy
  • 38. HISTORY AND SYMPTOMS • Possible history of systemic hypertension • Systemic hypertension largely asymptomatic • Hypertensive retinopathy largely asymptomatic • The eye examination will often give the first clue of systemic hypertension
  • 39. DIAGNOSIS Ophthalmoscopy (non-malignant retinopathy) • Arteriosclerosis from chronic disease  focal arteriolar narrowing  arterio-venous crossing changes -venous constriction and deflection -distal banking  arteriolar colour changes  vessel sclerosis • Similar signs with ageing
  • 40. CONT.. • Sphygmomanometry • Blood pressure measurement is required to make a positive diagnosis in the absence of malignant retinopathy changes
  • 41. DISC OEDEMA AND HAEMORRHAGES
  • 44. BASED ON PRESENCE OF SYSTEMIC HTN AND RETINAL EXAM:
  • 45. MANAGEMENT 1). Control Systemic Hypertension • Life style modification to control systemic HTN • Drugs to reduce systemic HTN 2) Hypertensive Retinopathy with visual threatening complications e.g retinal edema • With laser therapy • Intravitreal injection of vascular endothelial growth factors(VEGF)
  • 46.
  • 47. REFFERENCES • American Academy of ophthalmology • Comprehensive Ophthalmology 9th Edition A K Khurana • Kanski 9th Edition Clinical Ophthalmology.
  • 48. • Magara, G. M. (2022). Prevalence of Uncontrolled Hypertension and Associated Factors among Hypertensive Patients Attending Medical Outpatient Clinic, Thika Level 5 Hospital, Kiambu County, Kenya (Doctoral dissertation, JKUAT- COHES). • Rakwach, M. O. (2021). Prevalence and risk factors for hypertensive retinopathy at Moi Teaching and Referral Hospital, Eldoret, Kenya (Doctoral dissertation, Moi University).